Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
31 January 2014
Header
Header image
Highlight of the week

From our blog

#EFPIALIVE – A Conversation on the Year Ahead for Pharma
31 January 2014 by Richard Bergström

Earlier this week I spoke at the EFPIA event #EFPIALIVE – what used to be called the “director general lecture”. This year we wanted to [...] Read more

News

News

Putting animal welfare principles and 3Rs into action: European Pharmaceutical Industry 2012 Report Update
27 January 2014

This report actually offers you the best of both worlds as it is produced in an interactive pdf format which can be used just like [...] Read more

News

Minutes from EUnetHTA-EFPIA exploratory meeting - 5 November 2013
30 January 2014

As part of the framework for collaboration, delegations of EUnetHTA and EFPIA representatives met on 5 November 2013 to discuss the pilots of relative effectiveness [...] Read more

Events calendar

Events Calendar

World Cancer Day
On 04/02/2014

World Cancer Day 2014 (4 February 2014) will build on the success of last year's campaign, by again focusing on Target 5 of the World Cancer Declaration: Reduce [...] Read more

What we are reading

What we are reading

Researchers Discover Treatment for Rare Blood Cancer
31 January 2014

University of British Columbia researchers have discovered a potential new treatment for a rare blood cancer that may also point the way to treating other more common diseases. Paroxysmal nocturnal hemoglobinemia (PNH) is a rare form of cancer characterized by episodic rupture of red blood cells and the danger of blood clots forming in the vascular system. The condition results in red blood cells becoming vulnerable to attacks by the body’s own complement immune system and can lead to complications such as anemia, kidney disease and fatal thromboses.

Read more

What we are reading

Gamifying healthcare for patients
31 January 2014

Whatever you think you know about mobile health apps – how they’re helping patients stick to their pill schedule, or how they’re encouraging them to eat better or do more exercise – well, they’re doing it all wrong, according to Michael Fergusson, CEO of Ayoga Health Inc. As the CEO of a company that develops social games for patients, he has spent a lot of time pondering what makes a health-related, mobile app not only useful, but also fun.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail